Full name
AVI-PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
AVI-PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. OKRĘŻNA 8, 62-080 TARNOWO PODGÓRNE
TAX ID7812005534
Rate company:
AVI-PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7812005534
KRS0000824845
Share capital10,000.00 zł
address
UL. OKRĘŻNA 8, 62-080 TARNOWO PODGÓRNE
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7812005534
REGON
385363951
KRS
0000824845
Legal form
limited liability company
Register Address
UL. OKRĘŻNA 8, 62-080 TARNOWO PODGÓRNE
Date of registration in KRS
2020-01-22
Date of commencement of economic activity
2020-01-22
Act signature
PO.VIII NS-REJ.KRS/35269/19/141/ADE
Pkd codes
75.00.Z - Veterinary activities
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
49.41.Z - Road freight transport
68.20.Z - Rental and management of own or leased real estate
70.10.Z - Head office activities
70.22.Z - Head office activities and management consultancy
71.20.A - Food quality testing and analysis
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale  | -1,9 | -3,4 | -180,7 | -5169,9 |
Gross profit (loss) | -2,6 | -5,4 | -72,4 | -1244,6 |
EBITDA | -1,9 | -3,4 | -180 | -5159 |
Short time liabilities | 0,2 | 4,5 | 89,2 | 1877,2 |
Other operating costs | 0 | 0 | 0 | -∞ |
Equity capital | 5,1 | -0,3 | -95,3 | -35 575,7 |
Operating profit (EBIT) | -1,9 | -3,4 | -180 | -5159 |
Assets | 5,3 | 54,2 | 393,9 | 626,2 |
Net profit (loss) | -2,8 | -5,4 | -95,1 | -1665,6 |
Cash | 3,4 | 16,6 | 71,3 | 329,4 |
Net income from sale | 0 | 0 | 37,4 | -∞ |
Liabilities and provisions for liabilities | 0,2 | 54,5 | 489,2 | 797,5 |
Working assets | 4,3 | 20,2 | 360,7 | 1681,6 |
Other income costs | 0 | 0 | 0,7 | 11 656,7 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -54,9 | 2014,7 | 99,7 | -1915 |
Equity capital to total assets | 96,4 | -0,5 | -24,2 | -23,7 |
Gross profit margin | -193,4 | |||
EBITDA Margin | -480,9 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 870 | -2 147 482 778 |
Current financial liquidity indicator | 22.85221290588379 | 4.485891342163086 | 4.042059421539307 | -0,5 |
Net dept to EBITDA | 1.758873701095581 | -9.755217552185059 | -1.8261244297027588 | 8 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download docx01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.